SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001308179-24-000578
Filing Date
2024-04-25
Accepted
2024-04-25 16:02:32
Documents
11

Document Format Files

Seq Description Document Type Size
1 REGENERON PHARMACEUTICALS, INC. - DEFA14A lregn2024_defa14a.htm DEFA14A 33676
2 GRAPHIC check01.jpg GRAPHIC 1373
3 GRAPHIC logo.jpg GRAPHIC 12161
4 GRAPHIC lregn2024_defa14ax1x1.jpg GRAPHIC 49061
5 GRAPHIC lregn2024_defa14ax1x2.jpg GRAPHIC 5163
6 GRAPHIC lregn2024_defa14ax1x3.jpg GRAPHIC 3186
7 GRAPHIC lregn2024_defa14ax1x4.jpg GRAPHIC 7360
8 GRAPHIC lregn2024_defa14ax1x5.jpg GRAPHIC 6871
9 GRAPHIC lregn2024_defa14ax2x1.jpg GRAPHIC 1098
10 GRAPHIC lregn2024_defa14ax2x3.jpg GRAPHIC 1093
11 GRAPHIC uncheck.jpg GRAPHIC 1042
  Complete submission text file 0001308179-24-000578.txt   158074
Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9148477000
REGENERON PHARMACEUTICALS, INC. (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19034 | Film No.: 24876108
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)